# Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects

Study · id `cardio:ct-nct01273337` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01273337](<https://clinicaltrials.gov/study/NCT01273337>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01273337

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01273337. Randomized; quadruple masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01273337, source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01273337, source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)
- Primary completion: 2014-07 (anticipated) (ClinicalTrials.gov record NCT01273337, source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)
- Completion: 2015-01 (anticipated) (ClinicalTrials.gov record NCT01273337, source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01273337, source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01273337-2014-01-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects
- Condition: Stroke
- Condition: Ischemic Stroke
- Condition: Stroke in Middle Cerebral Artery (MCA)
- Intervention (Biological): ALD-401
- Intervention (Procedure): Sham Procedure
- Lead sponsor: Aldagen
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke) (`cardio:pubmed-30586746`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: df6274daa35178bdbe17a6f85d597f25c1b3ed08b27682ebe8cecf6d035c1cdb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
